Anti-ADAM33 oligonucleotides and related methods
US11401519B2 · kind B2 · utility
0Cited by
5References
48Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 6, 2018 |
| Grant date | Aug 2, 2022 |
| Priority date | — |
| Expiry date | Sep 25, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y304/24
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present disclosure provides antisense compounds, methods, and compositions for silencing ADAM33 mRNA. The present disclosure provides antisense compounds, methods, and compositions for the treatment, prevention, or amelioration of diseases, disorders, and conditions associated with ADAM33 in a subject in need thereof. Also contemplated are antisense compounds and methods for the preparation of a medicament for the treatment, prevention, or amelioration of a disease, disorder, or condition associated with ADAM33.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.